OT
Oncotelic Therapeutics, Inc.
SEC filingBiotechnology · Agoura Hills, CA
Amount raised$712Ksold at filing
Total offering$712K
Investors in the raise33count reported to the SEC
FiledJul 22, 2026first sale Jul 10, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
SARAN SAUNDExecutive Officer
STEVEN KINGDirector
VUONG TRIEUExecutive Officer, Director
SHAH AMITExecutive Officer
ANTHONY MAIDAExecutive Officer, Director
SEYMOUR FEINExecutive Officer
Executive officers, directors and promoters as listed on the Form D.